Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

Novo Nordisk's shares plunged more than 20% Tuesday, after the company cut the forecast for its flagship obesity drug. Before the markets opened, the company announced that sales of its obesity ...

With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, the FDA announced that all doses of Novo Nordisk’s Ozempic and Wegovy ...

In the midst of an anesthetic drug shortage, some physicians are turning to compound pharmacies rather than drug companies for supplies, according to a KTHV report. Rather than sell manufactured drugs ...

ORLANDO, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Olympia and Wesley Pharmaceuticals, two of the nation’s leading compound pharmacies, announced today that their CEO, Mark Mikhael, PharmD, has been ...